RN7SL635P

Across TCGA pan-cancer cohorts, RN7SL635P RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated RN7SL635P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher RN7SL635P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL635P expression acts as an unfavorable survival marker, although some lineages such as LUAD and OV show a favorable association.

MESO, READ, and LUAD are the cancer types where RN7SL635P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Tertile	All	0.132	0.511	.006	54	view →
READ	OS	Tertile	II,III,IV	0.173	0.818	<.001	45	view →
LUAD	DFS	Tertile	III,IV	0.907	0.399	.004	41	view →
STAD	OS	Median	IV	0.156	0.511	.001	31	view →
OV	DFS	Quartile	All	0.605	0.519	.019	26	view →
PRAD	OS	Tertile	All	0.566	0.944	<.001	24	view →
COAD	OS	Tertile	IV	0.045	0.659	<.001	18	view →
CESC	DFS	Tertile	II,III,IV	0.567	0.798	.032	18	view →
LUSC	DFS	Tertile	III,IV	0.139	0.782	.001	18	view →
KIRC	DFS	Tertile	IV	0.300	0.523	.044	18	view →
SKCM	OS	Tertile	IV	0.179	0.727	<.001	12	view →
UCEC	DFS	Tertile	All	0.824	0.905	.012	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

RN7SL635P–MESO (DFS)

Open the MESO breakdown →